Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
We have long had information that the lysate is a bit of a Swiss Army knife for repairing and protecting skin, opportunities have long been aplenty. I recognise we have been waiting for Croda to finish their work so the manufacturing begins, but I sincerely hope groundwork has been laid for various offshoots of commercialisation since as far back as the Manchester meet when we were told of the potential within.
And more opportunities for the lysate?
https://www.manxradio.com/news/uk-business/popular-sunscreens-fail-safety-test-as-and1632-49-rival-passes-with-flying-colours/
What a selling point for Croda, they also will be acutely aware of the results from the acne trial.
Seams like skinbiotix introduction will ne timed perfectly to enable companies to comply with the new EU law restricting t g e amount of retinol considered safe in skin products.https://www.independent.co.uk/extras/indybest/fashion-beauty/beauty/eu-retinol-ban-b2511235.html
This company IMO is going no where because of its terrible leadership by SA, his failed promises have lost a lot of people money he just and never had the skills of a CEO. The share price languishes at 10p, it will never see higher because of him
Disco, no it will not be happening anytime soon. SA has stated he wants to negotiate from a position of strength, so before any negotiations start I would suggest we focus on clearing the CB, get the Modi forecasts and Croda forecast, then hopefully we will be in a position of strength.
Disco I’d suggest it depends on how much of what SA has previously said is hard fact and what is exaggeration. We have previously been told there are multiple interested parties, which would usually mean at least one would be trying to close a deal fast to beat the competition. I doubt SA would be the one holding a deal off particularly given the SP decline over the last few years. It has been said for a long time the multinationals, plural, need to see that SBTX is not a one trick pony. The acne study proves this along with the Psoriasis product and the ongoing successful work with Croda and with the oral and inflammation research.
I wouldn’t expect SA to have a deal sewn up too soon, it will be fairly complicated and we already know these things take time. What I would certainly expect is for SA to let us know in his IMC presentation is what the reasonable next steps are to successfully commercialising the product and bringing in revenue to SBTX. Has a partner been selected/ how far on are the discussions/ has a structure and any numbers been discussed, and eventually, some forecasts, which any large company taking a whole pillar should be able to provide in advance. In fact, SA would be crazy to do a deal for such a large chunk of the company’s prospects without studying said forecasts. Fingers crossed we’ll know most of the above in the next 10 days.
Now we have the results of the acne trial, we are no longer a 'one-trick pony'.
We know that skin can't afford to market this product to its full potential, and it has been said before that a multinational would be interested in our products, especially if there is more than one, and acne is a huge market globally. So you would think someone has to be interested.
If a deal was to happen, could it be happening soon? I would presume the potential partner would have been waiting on these results. What do you all think?
Thinking our product treat the cause from within. Steroid cream and tablets commonly prescribed to treat the condition of bad skin. Its just what most doctors do not saying its right.
Steroids are indeed sometimes used to suppress very inflamed acne spots but use is very short term.They do not treat the condition as such and I would stick with my view that use of steroids for acne is quite unusual and Im not sure if any of the steroid creams has acne as a treatment indication but I could be wrong.
In other words it's a very decent outcome from the study. I'm sure steroid creams are and have been used for acne. All in all what's not to like?
As presented the results of this study are interesting enough and I have to say promising and suggest this product may help acne.Its good enough to provide enough evidence to support the promotion of axisbiotix for skin conditions.
Some caveats
As previously mentioned this was not a double blind study and some results were leaked and hyped half way through the study which is a bit odd given that it was run by an independent study company.This was not mentioned in the report produced in the RNS.No mention of statistical significance in the study report.Steroid creams were mentioned but it would be unusual to use steroid creams in the treatment of acne.
In summary the study is useful and indicates that this product may be a useful treatment for acne but contrary to some comments on here does not provide proof of efficacy.
You may be madabouttech but know nothing about science and studies.
An unblinded study with some results released during the study does not prove anything.
I will have a look at the results and give an independent study appraisal on here soon.
It is actually. The ‘rule of 30’ states that a study of 30 or more is likely to be statistically significant. L’Oreals Retinol Night Serum had a study of 49.
From day 1 this company has always had sellers when good news has been released. Going all the way back to IPO so to blame current management is just plain silly. Who do you think ran this study, and the last one too? If they can clear the loan note then all assumed sins will be forgiven.
Takenorisk, these results were never going to move the share price. What will move the share price is the CB being removed and then forecasts which will give investors confidence that there will be no more dilution in any form and that we will shortly be generating cash.
Let's hope this is a good omen for the croda results
91 participants that completed the exit survey ,,,, why such a low low number 91 .... what a poor sample ... not convincing at all
Sadly the price movement following an excellent rns reflects the confidence in the companies management
Haha
Yes, excellent results but as you say Mad we need the CB clearing, then Modi forecast, then Croda forecast.
Jury is still out on UMG taking Axis until it has proven what it can do with Derma. A forecast after nearly four months would be a good start!
These are excellent results and worth the wait. Surely this proves that the science works and will now attract a deal with a multinational? We just need that infernal loan note to be removed and the shackles should be well and truly released.
Taken at face value and without going further than skin deep , this is excellent.
Great results, but I think after the disappointing sales with axis psoriasis,
We are going to need a commercial partner to drive this forward.